Kornitzer Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.59M Buy
+37,245
New +$4.05M 0.12% 173
2022
Q1
Sell
-104,575
Closed -$10.5M 514
2021
Q4
$10.5M Sell
104,575
-23,355
-18% -$2.42M 0.16% 215
2021
Q3
$16M Hold
127,930
0.25% 161
2021
Q2
$15.9M Buy
127,930
+26,790
+26% +$3.6M 0.24% 169
2021
Q1
$15.4M Buy
101,140
+28,220
+39% +$4.26M 0.25% 155
2020
Q4
$9.4M Sell
72,920
-19,425
-21% -$2.24M 0.16% 208
2020
Q3
$10.3M Sell
92,345
-218
-0.2% -$19.9K 0.2% 165
2020
Q2
$7.51M Buy
+92,563
New +$7.46M 0.15% 204
2019
Q1
Sell
-55,765
Closed -$2.1M 482
2018
Q4
$2.1M Buy
+55,765
New +$2.05M 0.04% 307

Other funds holding GH

Kornitzer Capital Management's GH Position: Q2 2026 in Review

Kornitzer Capital Management opened a new position in Guardant Health (GH) in Q2 2026: 37,245 shares worth $5.59M. The stake represents 0.12% of the portfolio and ranks #173 among its holdings. This is a return to the name: Kornitzer Capital Management previously reported a position in GH as recently as Q4 2021.

Kornitzer Capital Management first reported a position in GH in Q4 2018 and has held it in 9 quarters since. The position peaked at $16M in Q3 2021. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Kornitzer Capital Management held 37,245 shares of Guardant Health worth $5.59M as of Q2 2026.
  • Guardant Health was a new Kornitzer Capital Management position in Q2 2026.
  • Guardant Health made up 0.12% of Kornitzer Capital Management's portfolio in Q2 2026, its #173 holding.
  • Kornitzer Capital Management first reported a position in Guardant Health in Q4 2018 and has held it in 9 quarters since.
  • Kornitzer Capital Management's Guardant Health position peaked at $16M in Q3 2021.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.